Continuum Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Sell |
815
-103
| -11% | -$40.1K | 0.04% | 328 |
|
|
2025
Q1 | $399K | Buy |
918
+85
| +10% | +$37K | 0.05% | 273 |
|
|
2024
Q4 | $307K | Buy |
833
+133
| +19% | +$49.1K | 0.04% | 320 |
|
|
2024
Q3 | $285K | Buy |
700
+103
| +17% | +$41.9K | 0.04% | 332 |
|
|
2024
Q2 | $323K | Buy |
597
+59
| +11% | +$32K | 0.05% | 288 |
|
|
2024
Q1 | $290K | Sell |
538
-1,680
| -76% | -$905K | 0.04% | 311 |
|
|
2023
Q4 | $1.05M | Sell |
2,218
-168
| -7% | -$79.2K | 0.15% | 166 |
|
|
2023
Q3 | $1.04M | Buy |
2,386
+850
| +55% | +$370K | 0.17% | 157 |
|
|
2023
Q2 | $682K | Buy |
1,536
+208
| +16% | +$92.4K | 0.11% | 225 |
|
|
2023
Q1 | $611K | Buy |
1,328
+31
| +2% | +$14.3K | 0.1% | 234 |
|
|
2022
Q4 | $665K | Buy |
1,297
+67
| +5% | +$34.4K | 0.12% | 209 |
|
|
2022
Q3 | $559K | Buy |
1,230
+27
| +2% | +$12.3K | 0.1% | 220 |
|
|
2022
Q2 | $581K | Buy |
1,203
+474
| +65% | +$229K | 0.11% | 231 |
|
|
2022
Q1 | $366K | Buy |
+729
| New | +$366K | 0.07% | 284 |
|